Labetalol infusion for refractory hypertension causing severe hypotension and bradycardia: an issue of patient safety, Patient Safety in Surgery

Por um escritor misterioso
Last updated 23 maio 2024
Labetalol infusion for refractory hypertension causing severe hypotension  and bradycardia: an issue of patient safety, Patient Safety in Surgery
Incremental doses of intravenous labetalol are safe and effective and, at times, such therapy may need to be augmented by a continuous infusion of labetalol to control severe hypertension. Continuous infusions of labetalol may exceed the recommended maximum daily dose of 300 mg on occasion. We report a case in which hypertension occurring after an abdominal aortic aneurysm repair, initially responsive to intermittent intravenous beta-blockade, became resistant to this therapy leading to the choice of an intravenous labetalol infusion as the therapeutic option. The labetalol infusion resulted in a profound cardiovascular compromise in this postoperative critically ill patient. While infusions of labetalol have successfully been used, prolonged administration in the intensive care unit requires vigilance and the establishment of a therapeutic rationale/policy for interventions, such as the ready availability of glucagon, β-agonists, phosphodiesterase inhibitors, insulin, and vasopressin when severe cardiovascular depression occurs.
Labetalol infusion for refractory hypertension causing severe hypotension  and bradycardia: an issue of patient safety, Patient Safety in Surgery
Frontiers Traumatic Brain Injury—A Review of Intravenous Fluid Therapy
Labetalol infusion for refractory hypertension causing severe hypotension  and bradycardia: an issue of patient safety, Patient Safety in Surgery
Hypertension during the Acute Phase of Stroke
Labetalol infusion for refractory hypertension causing severe hypotension  and bradycardia: an issue of patient safety, Patient Safety in Surgery
LABETALOL HCl by HF Acquisition Co LLC, DBA HealthFirst LABETALOL HCL injection
Labetalol infusion for refractory hypertension causing severe hypotension  and bradycardia: an issue of patient safety, Patient Safety in Surgery
The Safety of High Dose Labetalol in the Pregnant Population
Labetalol infusion for refractory hypertension causing severe hypotension  and bradycardia: an issue of patient safety, Patient Safety in Surgery
Hypertensive emergency - EMCrit Project
Labetalol infusion for refractory hypertension causing severe hypotension  and bradycardia: an issue of patient safety, Patient Safety in Surgery
Comparing Labetalol and Nitroglycerine on Inducing Controlled Hypotension and Intraoperative Blood Loss in Rhinoplasty: A Single-Blinded Clinical Trial, Anesthesiology and Pain Medicine
Labetalol infusion for refractory hypertension causing severe hypotension  and bradycardia: an issue of patient safety, Patient Safety in Surgery
Labetalol Hydrochloride Injection, USP Rx only
Labetalol infusion for refractory hypertension causing severe hypotension  and bradycardia: an issue of patient safety, Patient Safety in Surgery
Acute Hypertension Management in the ICU
Labetalol infusion for refractory hypertension causing severe hypotension  and bradycardia: an issue of patient safety, Patient Safety in Surgery
Pharmacology Basicmedical Key
Labetalol infusion for refractory hypertension causing severe hypotension  and bradycardia: an issue of patient safety, Patient Safety in Surgery
Treatment for Mild Chronic Hypertension during Pregnancy
Labetalol infusion for refractory hypertension causing severe hypotension  and bradycardia: an issue of patient safety, Patient Safety in Surgery
Cancers, Free Full-Text
Labetalol infusion for refractory hypertension causing severe hypotension  and bradycardia: an issue of patient safety, Patient Safety in Surgery
The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019)
Labetalol infusion for refractory hypertension causing severe hypotension  and bradycardia: an issue of patient safety, Patient Safety in Surgery
LABETALOL HYDROCHLORIDE INJECTION USP
Labetalol infusion for refractory hypertension causing severe hypotension  and bradycardia: an issue of patient safety, Patient Safety in Surgery
Labetalol Hydrochloride
Labetalol infusion for refractory hypertension causing severe hypotension  and bradycardia: an issue of patient safety, Patient Safety in Surgery
Frontiers Beta-Adrenergic Blockade in Critical Illness

© 2014-2024 taninn.co. All rights reserved.